Form 8-K - Current report:
SEC Accession No. 0001104659-23-105038
Filing Date
2023-09-29
Accepted
2023-09-29 07:50:20
Documents
16
Period of Report
2023-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2327162d1_8k.htm   iXBRL 8-K 45226
2 EXHIBIT 99.1 tm2327162d1_ex99-1.htm EX-99.1 248196
3 EXHIBIT 99.2 tm2327162d1_ex99-2.htm EX-99.2 11624
8 GRAPHIC tm2327162d1_ex99-2img001.jpg GRAPHIC 5951
  Complete submission text file 0001104659-23-105038.txt   615381

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gpcr-20230929.xsd EX-101.SCH 3893
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gpcr-20230929_def.xml EX-101.DEF 27150
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gpcr-20230929_lab.xml EX-101.LAB 37075
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gpcr-20230929_pre.xml EX-101.PRE 25774
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2327162d1_8k_htm.xml XML 5715
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41608 | Film No.: 231291890
SIC: 2834 Pharmaceutical Preparations